Records 1-4 (of 4 Records) |
Query Trace: APOB[original query] |
---|
Simvastatin Therapy Increased miR-150-5p
Expression in the Patients with Type 2 Diabetes and COVID-19. AmeliMojarad Mandana, et al. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2022 0 0. (6) 685-691 |
Association of polymorphisms in genes encoding prothrombotic and cardiovascular risk factors with disease severity in COVID-19 patients: a pilot study. Lapic Ivana, et al. Journal of medical virology 2022 0 0. |
Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network. Gao Qian, et al. Scientific reports 2022 0 0. (1) 188 |
Causal Associations Between Blood Lipids and COVID-19 Risk: A Two-Sample Mendelian Randomization Study. Zhang Kun, et al. Arteriosclerosis, thrombosis, and vascular biology 2021 0 0. ATVBAHA121316324 |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 18, 2024
- Content source: